Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool October 3, 2008 Brian Orelli	Guidance Up; Stock Price Down Agriculture investors remain wary.
The Motley Fool May 28, 2009 Brian Orelli	Monsanto Plowed Down Low end of guidance is better than lowered guidance, I guess.
The Motley Fool September 16, 2008 Brian Orelli	Monsanto's Guidance Keeps Growing Monsanto announces another change in financial guidance, which fortunately continued the upward trend.
The Motley Fool June 29, 2005 Stephen D. Simpson	Feast or Famine at Monsanto Disappointing guidance will hurt the agribusiness company's stock, but the business still seems quite good.
The Motley Fool January 6, 2010 Brian Orelli	Monsanto Needs to Round Up Some Growth Monsanto announces a $0.03 first-quarter loss compared with $1.00 per share of income a year ago. That's not exactly starting the year off on the right foot.
The Motley Fool March 26, 2008 Brian Orelli	Monsanto's Guidance Grows Like a Weed The company has had good reasons to set its sights higher. Can Monsanto's current upbeat news keep going strong?
The Motley Fool April 4, 2006 Rich Smith	Foolish Forecast: Monsanto Still Growing Although the winter quarter isn't usually strong for agriculture, Monsanto's rolling numbers support its CEO's assessment of the business. Over the past 18 months, the company has managed to grow its gross margins 60 basis points. Investors, take note.
The Motley Fool January 4, 2008 Brian Orelli	Monsanto Rounds Up Growth Sales grew 36% year-over-year at Monsanto; since sales growth significantly outpaced costs, the bottom line looked even better, with diluted EPS nearly tripling.
The Motley Fool June 29, 2010 Brian Orelli	Foolish Forecast: Monsanto 2.0 With Monsanto's herbicide Roundup facing cheap generic competition, the agriculture giant has planted its hopes for growth solely in the field of biotech seeds.
The Motley Fool June 22, 2004 Brian Gorman	More Green for Monsanto The full-year earnings the agribusiness giant Monsanto may not please everyone, but the company plants roots for long-term success.
The Motley Fool June 29, 2011 Brian Orelli	Monsanto Is Back From the Dead Roundup makes a triumphant return, but investors should focus on the seed business.
The Motley Fool January 8, 2009 Brian Orelli	Monsanto's Back! Monsanto blew the doors off Wall Street's estimates, and raised yearly guidance by 5% at the low end.
The Motley Fool September 11, 2009 Brian Orelli	Monsanto Plowed Down Is it bad news, or a bad-news buy?
The Motley Fool June 26, 2008 Brian Orelli	Why Throw Tomatoes at Monsanto? There wasn't a lot to complain about in Monsanto's third-quarter earnings report, but investors found enough disappointing news to send the stock down.
The Motley Fool January 11, 2012 Jacob Roche	Betting the Farm on Monsanto The biotech giant sits at the top of the food chain.
The Motley Fool April 2, 2009 Brian Orelli	Monsanto Rounds Up Alternative Growth Forget Roundup. The agri-giant has a better plan.
The Motley Fool October 9, 2008 Brian Orelli	Is Monsanto Back? Investors are giddy about Monsanto again. Should they be?
BusinessWeek May 14, 2007 Gene G. Marcial	Betting The Farm On Monsanto Wall street analysts are trying to keep up with Monsanto's fast-growing sales and earnings as a major provider of agricultural products for farmers.
The Motley Fool October 6, 2010 Jared Cummans	Wednesday's ETF to Watch: Global Agriculture ETF Monsanto's earnings report puts this ETF in focus today.
The Motley Fool December 6, 2005 Brian Gorman	Monsanto's Trade Dividend The giant and competitors in agricultural biotechnology should enjoy rising sales in the developed world as subsidies come down. Investors, take note.
The Motley Fool May 11, 2004 Brian Gorman	Monsanto's Fallow Wheat Field Monsanto halts development of its controversial genetically modified spring wheat.
The Motley Fool January 2, 2007 Rich Duprey	Foolish Forecast: Monsanto Blooms What will crop up in the agricultural behemoth's first-quarter 2007 earnings?
The Motley Fool April 6, 2011 Eric Dutram	Wednesday's ETF to Watch: Market Vectors Agribusiness Fund (MOO) Monsanto reports earnings today.
The Motley Fool October 8, 2009 Toby Shute	Monsanto's Solid Year in Seeds The agriculture giant closes the books on a fine year and looks forward.
The Motley Fool April 9, 2007 Ryan Fuhrmann	Scrutinizing Monsanto's Outlook Food for thought about what's driving Monsanto. Investors, in many respects, considering Monsanto is more akin to finding opportunities in biotechnology than looking into the heartland.
The Motley Fool March 29, 2005 Stephen D. Simpson	Monsanto Sows the Seeds of Growth The agricultural specialist hikes earnings guidance on the back of strong sales. The present valuation may look rich, but investors shouldn't underestimate this growing titan.
The Motley Fool October 13, 2005 Brian Gorman	Monsanto's Abundant Harvest The agricultural technology giant's strong 2005 results demonstrate that business is on track. As for the future, the company now expects fiscal 2006 earnings to be between $2.35 and $2.50 per share, up from a June prediction of $2.34.
The Motley Fool February 18, 2005 Brian Gorman	Monsanto Cottons to Emergent Monsanto's second acquisition in less than a month signals an aggressive move into cotton seeds. Investors will no doubt keep a close eye on this one.
The Motley Fool September 28, 2005 Brian Gorman	Monsanto's Rich Pipeline The agrochemical giant's long-term health looks assured thanks to a rich product pipeline. Investors, take note.
The Motley Fool January 4, 2007 Brian Gorman	Monsanto's Bigger Harvest? High corn prices could allow Monsanto to raise seed prices and improve margins. Investors, take note.
The Motley Fool April 3, 2008 Brian Orelli	Monsanto's Planting Its Seeds Strong growth from the agricultural giant, but will it last?
The Motley Fool January 6, 2011 Stoyan Bojinov	Thursday's ETF to Watch: Market Vectors Agribusiness ETF (MOO) Monsanto reports earnings today.
The Motley Fool September 17, 2010 Dave Mock	3 Reasons to Sell Monsanto Today Monsanto faces serious competitive threats on several fronts, threats that could continue to pressure the stock.
The Motley Fool June 24, 2009 Brian Orelli	The Death of a Cash Cow The company knew a drop in Roundup sales was coming with the patent expiring, but Monsanto has a backup plan.
The Motley Fool August 6, 2009 Brian Orelli	No More Flower Power for Monsanto Monsanto sells its sunflower business to rival Syngenta for $160 million.
The Motley Fool July 15, 2010 Brian Orelli	Insider Buying at Monsanto Monsanto's CEO and CFO bought shares. Should you?
The Motley Fool April 25, 2007	Corporate Executive Board Can't Please the Street: Fool by Numbers The business consultant released earnings for the first-quarter 2007: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool August 20, 2009 Brian Orelli	Monsanto Fights Back Monsanto and DuPont have escalated their squabble over DuPont's license of Monsanto's Roundup Ready gene.
The Motley Fool June 1, 2010 Jennifer Schonberger	The S&P 500's Biggest Movers Here are the five biggest S&P 500 upticks and five biggest S&P 500 drops of last week.
The Motley Fool August 2, 2007 Brian Orelli	Monsanto Counts Beans Agricultural giant Monsanto is one step closer to launching its new soybean. In field-testing the new seeds have demonstrated a 7%-11% increase in yield.
The Motley Fool December 5, 2006 Brian Gorman	Monsanto Needs to Charm The company has to confront concerns over genetically modified foods soon if it hopes to keep growing. Investors, take note.
The Motley Fool August 20, 2008 Brian Orelli	A Moooving Acquisition Eli Lilly buys Monsanto's cow hormone business.
The Motley Fool December 5, 2008 Brian Orelli	Monsanto Ready to Round Up Growth The company announces that the European Union has approved its genetically modified soybean seeds for import.
Chemistry World August 2, 2012	Monsanto wins $1bn in patent case A US court has awarded $1 billion in damages to Monsanto following a patent dispute with DuPont over crops bred to be resistant to the popular pesticide glyphosphate.
The Motley Fool April 6, 2005 W.D. Crotty	Fast-Blooming Biotech Monsanto's net sales and net income soar in the second quarter. Is it time to buy this stock?
The Motley Fool October 10, 2011 Dan Caplinger	Has Monsanto Become the Perfect Stock? Monsanto may not be perfect yet, but it's in the right place at the right time and has the opportunity to keep making money from a firmly entrenched trend.
Registered Rep. April 1, 2006 Bob Hirschfeld	Good Breeding Ag-biotech is entering a period of vibrant growth as farmers, not only in the U.S., but Brazil, India and China increase usage of the highly productive seeds. Is Wall Street valuing shares of ag-biotech companies correctly?
The Motley Fool December 15, 2009 Brian Orelli	Why Does Everyone Hate Monsanto? Sometimes the mean guy wins.
The Motley Fool November 10, 2005 Rich Smith	Cisco Gets a C Cisco gets at best a passing grade for its first-quarter earnings. The discrepancy between reported profits and actual cash generation appears to be getting worse. Investors, take note.
The Motley Fool March 2, 2005 Brian Gorman	Monsanto's Brazil Benefit Brazil is on the cusp of legalizing genetically modified seed sales, a potential boon for Monsanto.